Link Pharma Chem Share Price Today

Link Pharma Chem cites small size to skip RPT disclosure for H1FY27

Link Pharma Chem Ltd stated it is not required to disclose related party transactions for H1FY27. Paid-up equity share capital did not exceed ₹10 crore as on last day of previous financial year. Net worth remained below ₹25 crore, triggering exemption under Regulation 15(2). Company cited BSE Notice No. 20220425-30 to support non-applicability of Regulation 23(9).

Link Pharma Chem GST demand cut to ₹16.3 lakh for FY22

GST Appellate Authority reduced Link Pharma Chem's FY22 tax demand to ₹16.3 lakh. Penalty amount decreased from ₹13.29 lakh to ₹2.05 lakh following the order. Dispute centered on GSTR1-GSTR3B mismatches and excess ITC on imports. Company plans to appeal the remaining liability despite reduced impact.

Link Pharma Chem re-appoints Satish G. Thakur as Chairman for three years

Link Pharma Chem re-appointed Satish G. Thakur as Chairman and WTD for three years effective June 24, 2026. Rishikesh Thakur was re-appointed as Managing Director for a three-year term starting September 24, 2026. Shareholders approved all resolutions with 99.74% affirmative votes at the AGM on August 20, 2026. Voting participation stood at 58.97% of eligible shares, with promoters voting unanimously in favor.

Link Pharma Chem publishes Q1FY26 results in newspapers after profit turnaround

Link Pharma Chem returned to profitability in Q1FY26 with a net profit of ₹31.83 crore, up from a loss of ₹40.86 crore in Q4FY25. Revenue grew 12.2% YoY to ₹876.84 crore, supported by operational growth and fair value gains. The results were approved by the Board on August 5, 2026, and published in newspapers as per SEBI regulations.

Link Pharma Chem sets Aug 20 for 41st AGM; urges KYC updates

Link Pharma Chem Limited has announced its 41st Annual General Meeting for August 20, 2026, conducted via VC/OAVM. Key agenda items include the adoption of FY26 financial statements, re-appointment of Satish Thakur as director, and ratification of cost auditor remuneration. The company also highlighted the importance of updating KYC details for physical shareholders to comply with SEBI regulations and ensure electronic dividend payments.

Link Pharma Chem re-appoints Satish Thakur as Chairman

Link Pharma Chem Limited will re-appoint Mr. Satish G. Thakur as Chairman and Whole-time Director for a three-year term effective June 24, 2026, pending shareholder approval. Mr. Thakur, the father of the Managing Director, has over 43 years of experience and has been with the company since its inception.